Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-07

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)

View source ↗

Summary

The FDA approved a supplemental application for a generic form of bupropion hydrochloride from Apnar Pharma LP, allowing continued marketing of this antidepress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)